HSBC Holdings’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,409
| Closed | -$437K | – | 2741 |
|
|
2025
Q2 | $437K | Sell |
3,409
-7,102
| -68% | -$738K | ﹤0.01% | 2218 |
|
|
2025
Q1 | $914K | Sell |
10,511
-9,508
| -47% | -$928K | ﹤0.01% | 1792 |
|
|
2024
Q4 | $1.73M | Sell |
20,019
-11,795
| -37% | -$1.08M | ﹤0.01% | 1533 |
|
|
2024
Q3 | $2.9M | Buy |
31,814
+21,850
| +219% | +$2.17M | ﹤0.01% | 1306 |
|
|
2024
Q2 | $1.06M | Buy |
+9,964
| New | +$997K | ﹤0.01% | 1660 |
|
|
2023
Q4 | – | Sell |
-5,856
| Closed | -$298K | – | 2733 |
|
|
2023
Q3 | $298K | Sell |
5,856
-346
| -6% | -$18.5K | ﹤0.01% | 2224 |
|
|
2023
Q2 | $404K | Sell |
6,202
-9,138
| -60% | -$497K | ﹤0.01% | 2042 |
|
|
2023
Q1 | $689K | Sell |
15,340
-8,019
| -34% | -$361K | ﹤0.01% | 1922 |
|
|
2022
Q4 | $1M | Buy |
23,359
+4,269
| +22% | +$205K | ﹤0.01% | 1967 |
|
|
2022
Q3 | $1.28M | Sell |
19,090
-19,463
| -50% | -$1.25M | ﹤0.01% | 1723 |
|
|
2022
Q2 | $1.99M | Buy |
38,553
+12,872
| +50% | +$754K | ﹤0.01% | 1587 |
|
|
2022
Q1 | $1.66M | Buy |
+25,681
| New | +$1.84M | ﹤0.01% | 1692 |
|
|
2021
Q4 | – | Sell |
-3,701
| Closed | -$382K | – | 3259 |
|
|
2021
Q3 | $382K | Sell |
3,701
-2,478
| -40% | -$231K | ﹤0.01% | 2417 |
|
|
2021
Q2 | $544K | Buy |
6,179
+1,807
| +41% | +$166K | ﹤0.01% | 2116 |
|
|
2021
Q1 | $422K | Sell |
4,372
-3,248
| -43% | -$324K | ﹤0.01% | 2088 |
|
|
2020
Q4 | $854K | Buy |
+7,620
| New | +$803K | ﹤0.01% | 1805 |
|
|
2019
Q3 | – | Sell |
-2,521
| Closed | -$238K | – | 3066 |
|
|
2019
Q2 | $238K | Sell |
2,521
-254
| -9% | -$21K | ﹤0.01% | 2451 |
|
|
2019
Q1 | $222K | Buy |
+2,775
| New | +$205K | ﹤0.01% | 2497 |
|
Other funds holding BPMC
IA
HNB
HSBC Holdings's BPMC Position: Q3 2025 in Review
HSBC Holdings sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 3,409 shares — an estimated $437K sold.
HSBC Holdings first reported a position in BPMC in Q1 2019 and held it in 18 quarters. The position peaked at $2.9M in Q3 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- HSBC Holdings reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- HSBC Holdings sold 3,409 Blueprint Medicines shares in Q3 2025, an estimated $437K.
- HSBC Holdings first reported a position in Blueprint Medicines in Q1 2019 and held it in 18 quarters.
- HSBC Holdings's Blueprint Medicines position peaked at $2.9M in Q3 2024.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.